{"id":"https://openalex.org/W3118945652","doi":"https://doi.org/10.1093/ofid/ofaa439.1466","title":"1283. New Generation Antiviral Conjugate (AVC): Stable, Safe, and Single","display_name":"1283. New Generation Antiviral Conjugate (AVC): Stable, Safe, and Single","publication_year":2020,"publication_date":"2020-10-01","ids":{"openalex":"https://openalex.org/W3118945652","doi":"https://doi.org/10.1093/ofid/ofaa439.1466","mag":"3118945652","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7777659"},"language":"en","primary_location":{"id":"doi:10.1093/ofid/ofaa439.1466","doi":"https://doi.org/10.1093/ofid/ofaa439.1466","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofaa439.1466","pdf_url":"https://academic.oup.com/ofid/article-pdf/7/Supplement_1/S656/35341127/ofaa439.1466.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://academic.oup.com/ofid/article-pdf/7/Supplement_1/S656/35341127/ofaa439.1466.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090249918","display_name":"Voon S. Ong","orcid":"https://orcid.org/0000-0001-8676-6717","observed_orcids":["https://orcid.org/0000-0001-8676-6717"]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Voon Ong","raw_affiliation_strings":["Cidara Therapeutics, Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, Inc., San Diego, California","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112599402","display_name":"James M Levin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Levin","raw_affiliation_strings":["Cidara Therapeutics, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, California","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033169749","display_name":"Allen Borchardt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Allen Borchardt","raw_affiliation_strings":["Cidara Therapeutics, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, California","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111912606","display_name":"Thomas P. Brady","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas P Brady","raw_affiliation_strings":["Cidara Therapeutics, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, California","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039881624","display_name":"Thanh Lam","orcid":"https://orcid.org/0000-0002-4749-6096","observed_orcids":["https://orcid.org/0000-0002-4749-6096"]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thanh Lam","raw_affiliation_strings":["Cidara Therapeutics, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, California","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084759486","display_name":"Alain Noncovich","orcid":"https://orcid.org/0009-0003-9088-0434","observed_orcids":["https://orcid.org/0009-0003-9088-0434"]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alain Noncovich","raw_affiliation_strings":["Cidara Therapeutics, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, California","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090771280","display_name":"Joanne Fortier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joanne Fortier","raw_affiliation_strings":["Cidara Therapeutics, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, California","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076930062","display_name":"Karin Amundson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karin Amundson","raw_affiliation_strings":["Cidara Therapeutics, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, California","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010350552","display_name":"Jeffrey B. Locke","orcid":"https://orcid.org/0000-0001-8145-0828","observed_orcids":["https://orcid.org/0000-0001-8145-0828"]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey B Locke","raw_affiliation_strings":["Cidara Therapeutics, Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, Inc., San Diego, California","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077244168","display_name":"Amanda L. Almaguer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amanda Almaguer","raw_affiliation_strings":["Cidara Therapeutics, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, California","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034341152","display_name":"Nicholas Dedeic","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas Dedeic","raw_affiliation_strings":["Cidara Therapeutics, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, California","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049077059","display_name":"Grayson Hough","orcid":"https://orcid.org/0009-0003-4960-2811","observed_orcids":["https://orcid.org/0009-0003-4960-2811"]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Grayson Hough","raw_affiliation_strings":["Cidara Therapeutics, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, California","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064006920","display_name":"Jason N. Cole","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason Cole","raw_affiliation_strings":["Cidara Therapeutics, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, California","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023107683","display_name":"Simon D\u00f6hrmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Simon D\u00f6hrmann","raw_affiliation_strings":["Cidara Therapeutics, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, California","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104320373","display_name":"Rajvir Grewal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rajvir Grewal","raw_affiliation_strings":["Immunology, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunology, San Diego, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041658712","display_name":"Elizabeth Abelovski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Abelovski","raw_affiliation_strings":["Cidara Therapeutics, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, California","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010189871","display_name":"James M. Balkovec","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James M Balkovec","raw_affiliation_strings":["Cidara Therapeutics, Inc, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, Inc, San Diego, California","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mike Schlosser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mike Schlosser","raw_affiliation_strings":["Cidara Therapeutics, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, California","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029698229","display_name":"Ken F. Bartizal","orcid":"https://orcid.org/0000-0003-4357-4605","observed_orcids":["https://orcid.org/0000-0003-4357-4605"]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ken Bartizal","raw_affiliation_strings":["Cidara Therapeutics, Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, Inc., San Diego, California","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029561003","display_name":"Les Tari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Les Tari","raw_affiliation_strings":["Cidara Therapeutics, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, California","institution_ids":["https://openalex.org/I4210140218"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4053,"currency":"USD","value_usd":4053},"apc_paid":{"value":4053,"currency":"USD","value_usd":4053},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"7","issue":"Supplement_1","first_page":"S656","last_page":"S657"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10167","display_name":"Influenza Virus Research Studies","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10167","display_name":"Influenza Virus Research Studies","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.008799999952316284,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/influenza-a-virus","display_name":"influenza A virus","score":0.5830000042915344},{"id":"https://openalex.org/keywords/influenza-b","display_name":"influenza B","score":0.996999979019165},{"id":"https://openalex.org/keywords/small-molecule-antivirals","display_name":"small-molecule antivirals","score":0.8510000109672546},{"id":"https://openalex.org/keywords/fc-domain","display_name":"Fc domain","score":0.7250000238418579},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9620000123977661},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.3880000114440918},{"id":"https://openalex.org/keywords/prophylaxis","display_name":"prophylaxis","score":0.6589999794960022},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.8820000290870667},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.550000011920929},{"id":"https://openalex.org/keywords/neuraminidase","display_name":"neuraminidase","score":0.6069999933242798},{"id":"https://openalex.org/keywords/h1n1pdm09","display_name":"H1N1pdm09","score":0.6480000019073486},{"id":"https://openalex.org/keywords/h3n2","display_name":"H3N2","score":0.8690000176429749},{"id":"https://openalex.org/keywords/single-dose-administration","display_name":"single-dose administration","score":0.46799999475479126}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.717628002166748},{"id":"https://openalex.org/C134164806","wikidata":"https://www.wikidata.org/wiki/Q409485","display_name":"Neuraminidase","level":3,"score":0.6828100681304932},{"id":"https://openalex.org/C2777538117","wikidata":"https://www.wikidata.org/wiki/Q425196","display_name":"Neuraminidase inhibitor","level":5,"score":0.6421454548835754},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6212734580039978},{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.5665497779846191},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5510707497596741},{"id":"https://openalex.org/C85663871","wikidata":"https://www.wikidata.org/wiki/Q6966562","display_name":"Nasal administration","level":2,"score":0.48381417989730835},{"id":"https://openalex.org/C194409129","wikidata":"https://www.wikidata.org/wiki/Q103824","display_name":"Hematology","level":2,"score":0.44624608755111694},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34684133529663086},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33124396204948425},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.2259589433670044},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.15703710913658142},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1093/ofid/ofaa439.1466","doi":"https://doi.org/10.1093/ofid/ofaa439.1466","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofaa439.1466","pdf_url":"https://academic.oup.com/ofid/article-pdf/7/Supplement_1/S656/35341127/ofaa439.1466.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:6698422","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC7777659","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:7777659","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7777659/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infect Dis","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/ofid/ofaa439.1466","doi":"https://doi.org/10.1093/ofid/ofaa439.1466","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofaa439.1466","pdf_url":"https://academic.oup.com/ofid/article-pdf/7/Supplement_1/S656/35341127/ofaa439.1466.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3118945652.pdf","grobid_xml":"https://content.openalex.org/works/W3118945652.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3118240973","https://openalex.org/W3120145454","https://openalex.org/W3119220196","https://openalex.org/W2981705923","https://openalex.org/W4389031045","https://openalex.org/W7122385737","https://openalex.org/W4414964693","https://openalex.org/W4406923547","https://openalex.org/W4406950372","https://openalex.org/W4389029178"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"CD377":[2,32,54,147,185,209,217,301,323,349],"is":[3],"a":[4,20,36,87,137,143,176,181,278,303,342,351],"novel":[5,21,353],"antiviral":[6,24],"Fc-conjugate":[7],"(AVC)":[8],"development":[9],"candidate":[10],"for":[11,40,355],"influenza":[12,45,60,139],"prevention":[13,43,357],"and":[14,25,42,47,62,77,96,104,130,203,266,297,311,322,330,339,358],"treatment,":[15],"comprising":[16],"multiple":[17],"copies":[18],"of":[19,29,44,93,146,161,184,251,300,332,348,360],"potent":[22],"small-molecule":[23],"the":[26,67,159,346,356],"Fc":[27,98],"domain":[28],"human":[30],"IgG1.":[31],"was":[33,121,134,173,219,238,275],"designed":[34],"as":[35,350],"stable,":[37],"long-acting":[38],"molecule":[39,95],"treatment":[41,359],"A":[46,247],"B.":[48,417],"Studies":[49],"were":[50,81,99,205,227],"conducted":[51],"to":[52,153,258],"characterize":[53],"stability/pharmacokinetics":[55],"(PK),":[56],"single-dose":[57],"efficacy":[58,133,172,274,340],"in":[59,66,123,136,175,212,225,233,269,302,314],"models,":[61],"safety/toxicology.":[63],"Methods":[64],"PK":[65],"mouse":[68,140,178,270],"(1-100":[69],"mg/kg),":[70,73,76],"rat":[71],"(5-50":[72],"ferret":[74],"(3":[75],"monkey":[78,286],"(5-20":[79,125],"mg/kg)":[80,149,187],"studied":[82,135,174],"by":[83,101,201],"sampling":[84],"plasma":[85],"over":[86],"1-2":[88],"week":[89],"interval.":[90],"Plasma":[91,198],"levels":[92],"intact":[94,211],"total":[97],"measured":[100,200],"neuraminidase":[102],"(NA)-capture":[103],"Fc-capture":[105],"with":[106,157,194,277,335,341],"Fc-detection":[107],"ELISA,":[108],"respectively.":[109],"Two-week":[110],"safety/toxicology":[111],"(bodyweight,":[112],"coagulation,":[113],"clinical":[114],"signs,":[115],"chemistries,":[116],"hematology,":[117],"cytokines,":[118],"urinalsis,":[119],"histopathology)":[120],"evaluated":[122],"monkeys":[124],"mg/kg":[126,232,253,281],"on":[127,319],"days":[128,151,256],"1":[129,252],"8).":[131],"Prophylaxis":[132],"lethal":[138],"model":[141,179],"using":[142,180],"single":[144,182,248,279,343],"dose":[145,183,250],"(0.3\u20133":[148,186],"28":[150,255],"prior":[152,257],"intranasal":[154],"(IN)":[155],"challenge":[156,193,318],"3x":[158],"LD95":[160],"A/California/07/2009":[162],"(H1N1)pdm,":[163],"A/Hong":[164],"Kong/1/68":[165],"(H3N2),":[166],"or":[167,243],"B/Malaysia":[168],"(Victoria":[169],"lineage).":[170],"Treatment":[171,273],"similar":[177],"administered":[188,254],"2":[189],"hours":[190],"after":[191,240],"IN":[192],"A/CA/12/2012":[195],"(H1N1)pdm.":[196],"Results":[197],"concentrations":[199],"Fc-capture/Fc-detection":[202],"NA-capture/Fc-detection":[204],"comparable,":[206],"indicating":[207],"that":[208],"remained":[210],"vivo.":[213],"In":[214],"species":[215],"tested,":[216],"t1/2":[218],"3\u201310":[220],"days.":[221],"Dose":[222],"proportional":[223],"increases":[224],"exposure":[226],"observed,":[228],"notably":[229],"from":[230],"1\u2013100":[231],"mouse.":[234],"High":[235],"bioavailability":[236],"(77%)":[237],"observed":[239,276],"subcutaneous":[241],"(SC)":[242],"intramuscular":[244],"(IM)":[245],"administration.":[246],"SC":[249],"infection":[259,317],"provided":[260],"100%":[261],"protection":[262],"against":[263],"H1N1,":[264,309],"B,":[265],"H3N2":[267],"subtypes":[268],"(Fig.":[271],"1).":[272],"0.3":[280],"IM":[282],"dose.":[283],"The":[284,328],"2-week":[285],"toxicology":[287],"study":[288],"showed":[289],"no":[290],"adverse":[291],"effects.":[292],"Figure":[293],"1.":[294],"Efficacy":[295],"(Survival":[296],"Body":[298],"Weight)":[299],"28-Day":[304],"Prevention":[305],"Model":[306],"Against":[307],"Influenza":[308],"H3N2,":[310],"B":[312],"Subtypes":[313],"Mouse":[315],"(IN":[316],"Day":[320],"t=0":[321],"dosed":[324],"t\u201328":[325],"days).":[326],"Conclusion":[327],"stability":[329],"safety":[331],"CD377,":[333],"together":[334],"its":[336],"long":[337],"half-life":[338],"dose,":[344],"support":[345],"potential":[347],"long-acting,":[352],"AVC":[354],"influenza.":[361],"Disclosures":[362],"Voon":[363],"Ong,":[364],"PhD,":[365,373,379,393,399,419,449,455,476,483,491],"Cidara":[366,374,380,388,394,400,406,413,420,428,436,444,450,456,462,470,477,484,492],"Therapeutics,":[367,421,429,463,485],"Inc.":[368,422,430,464,486],"(Employee,":[369,408,423,431,465],"Shareholder)":[370,409,424,432,466,480,488],"James":[371,473],"Levin,":[372],"Therapeutics":[375,381,389,395,401,407,414,437,445,451,457,471,478,493],"(Shareholder)":[376,396,402,415,452,458,472,494],"Allen":[377],"Borchardt,":[378],"(Employee)":[382,390,438,446],"Thomas":[383],"P.":[384],"Brady,":[385],"PhD":[386],"Chemistry,":[387,443],"Thanh":[391],"Lam,":[392],"Alain":[397],"Noncovich,":[398],"Joanne":[403],"Fortier,":[404],"BSc,":[405],"Karin":[410],"Amundson,":[411],"B.S.,":[412,469],"Jeffrey":[416],"Locke,":[418],"Amanda":[425],"Almaguer,":[426],"Bachelors,":[427],"Nicholas":[433],"Dedeic,":[434],"n/a,":[435,461],"Grayson":[439],"Hough,":[440],"MS":[441],"-":[442],"Jason":[447],"Cole,":[448],"Simon":[453],"D\u00f6hrmann,":[454],"Rajvir":[459],"Grewal,":[460],"Elizabeth":[467],"Abelovski,":[468],"M.":[474],"Balkovec,":[475],"(Consultant,":[479,487],"Ken":[481],"Bartizal,":[482],"Les":[489],"Tari,":[490]},"counts_by_year":[],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2021-01-18T00:00:00"}